TNF inhibitors (infliximab, adalimumab, etanercept) are used in treating autoimmune diseases like rheumatoid arthritis, Crohn’s disease, ulcerative colitis, psoriasis, and ankylosing spondylitis [41,42,43,44]. This evidence concerns the gene TNF and ankylosing spondylitis.